John Hural

Title: John Hural: Innovator in Prostate Cancer Research

Introduction

John Hural is a notable inventor based in Bainbridge Island, WA (US). He has made significant contributions to the field of cancer research, particularly focusing on prostate cancer. With a total of 2 patents, Hural's work has the potential to impact the diagnosis and treatment of this prevalent disease.

Latest Patents

Hural's latest patents include innovative compositions and methods for the therapy and diagnosis of cancer, specifically prostate cancer. The first patent discloses compositions that comprise one or more prostate-specific polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cells that express these polypeptides, and T cells that are specific for cells expressing such polypeptides. These compositions are particularly useful in the diagnosis, prevention, and treatment of prostate cancer. The second patent reiterates similar themes, emphasizing the importance of these compositions in combating prostate cancer.

Career Highlights

John Hural is associated with Corixa Corporation, where he has been instrumental in advancing research related to prostate cancer. His work has garnered attention for its innovative approach to cancer therapy and diagnosis.

Collaborations

Hural has collaborated with notable colleagues, including Jiangchun Xu and Davin C Dillon, to further enhance the research and development of cancer therapies.

Conclusion

John Hural's contributions to prostate cancer research through his patents and collaborations highlight his commitment to improving cancer diagnosis and treatment. His innovative work continues to pave the way for advancements in the medical field.